ReviewInternational journal of molecular sciences2026
Immunoregenerative Microenvironment Modulation in Tendon-Ligament Regeneration: Evolution of Chitosan-Based Composite Biomaterials.
Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tendon and ligament injuries remain challenging to treat because healing may result in fibrosis, incomplete tendon-bone integration, impaired biomechanical properties, and reinjury. This review critically synthesizes preclinical evidence on chitosan-based composite biomaterials for tendon-ligament regeneration, focusing on their evolution from structural scaffolds toward multifunctional immunoregenerative platforms. Evidence across immune regulation, inflammatory signaling, angiogenesis, progenitor-cell activity, extracellular matrix remodeling, fibrocartilage formation, enthesis regeneration, tendon-bone healing, and biomechanical recovery was evaluated, while distinguishing direct chitosan-related evidence from contextual evidence derived from broader biomaterial systems. Chitosan-based platforms may support multiple regenerative domains through structural guidance, bioadhesion, localized delivery of bioactive components, and formulation-dependent immunomodulatory activity. However, heterogeneity in chitosan physicochemical properties, composite formulations, experimental models, and outcome measures limits direct comparison and prevents definitive attribution of multicomponent effects to chitosan alone. We propose the Immunoregenerative Cascade Theory and Immunoregenerative Tendon-Ligament Unit as complementary, hypothesis-generating frameworks for organizing temporal and spatial-functional interactions during regeneration. These frameworks are not validated causal or predictive models. Future research should prioritize standardized biomaterial characterization, longitudinal molecular-histological-biomechanical assessment, emerging multi-omics approaches, clinically relevant large-animal validation, and mechanism-guided biomaterial design to establish whether immunoregulatory effects translate into durable structural and functional tendon-ligament regeneration with long-term reproducible clinically meaningful recovery outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.